GB9902919D0 - Modulator of inflammation - Google Patents

Modulator of inflammation

Info

Publication number
GB9902919D0
GB9902919D0 GBGB9902919.1A GB9902919A GB9902919D0 GB 9902919 D0 GB9902919 D0 GB 9902919D0 GB 9902919 A GB9902919 A GB 9902919A GB 9902919 D0 GB9902919 D0 GB 9902919D0
Authority
GB
United Kingdom
Prior art keywords
inflammation
modulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9902919.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9902919.1A priority Critical patent/GB9902919D0/en
Publication of GB9902919D0 publication Critical patent/GB9902919D0/en
Priority to PCT/GB2000/000414 priority patent/WO2000047768A1/en
Priority to EP00902755A priority patent/EP1151137A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9902919.1A 1999-02-09 1999-02-09 Modulator of inflammation Ceased GB9902919D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9902919.1A GB9902919D0 (en) 1999-02-09 1999-02-09 Modulator of inflammation
PCT/GB2000/000414 WO2000047768A1 (en) 1999-02-09 2000-02-09 Modulator of inflammation
EP00902755A EP1151137A1 (en) 1999-02-09 2000-02-09 Modulator of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9902919.1A GB9902919D0 (en) 1999-02-09 1999-02-09 Modulator of inflammation

Publications (1)

Publication Number Publication Date
GB9902919D0 true GB9902919D0 (en) 1999-03-31

Family

ID=10847428

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9902919.1A Ceased GB9902919D0 (en) 1999-02-09 1999-02-09 Modulator of inflammation

Country Status (3)

Country Link
EP (1) EP1151137A1 (en)
GB (1) GB9902919D0 (en)
WO (1) WO2000047768A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044427A2 (en) * 2000-10-27 2002-06-06 President And Fellows Of Harvard College Cell based triple readout assay systems for identifying compounds that effect transcription
WO2002068627A2 (en) 2001-02-23 2002-09-06 Novartis Ag Vector constucts
ES2329986T3 (en) 2001-09-06 2009-12-03 Rapid Micro Biosystems Inc QUICK DETECTION OF CELLS IN REPLICATION.
DK2691411T3 (en) * 2011-03-29 2020-05-11 Glaxosmithkline Llc PROTEIN PURIFICATION BUFFER SYSTEM
CN107988345A (en) * 2017-12-05 2018-05-04 广东药科大学 The method of HLA-A*02 subtype typings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039146A1 (en) * 1996-04-12 1997-10-23 Cedars-Sinai Medical Center Methods of identifying and diagnosing inflammatory bowel disease
WO1997042820A1 (en) * 1996-05-16 1997-11-20 Duke University Tristetraprolin

Also Published As

Publication number Publication date
WO2000047768A1 (en) 2000-08-17
EP1151137A1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
GB9917567D0 (en) Variable order sigma-delta modulator
GB2349485B (en) Application management
AU2212600A (en) Antisense modulation of g-alpha-i1 expression
AU6296099A (en) Antisense modulation of g-alpha-12 expression
GB9909323D0 (en) Phase modulator
GB9922840D0 (en) An optical modulator
GB9912178D0 (en) Improved optical modulator
EP1206478A4 (en) Antisense modulation of mekk5 expression
AU7876900A (en) Antisense modulation of fra-1 expression
AU2209000A (en) Antisense modulation of pepck-mitochondrial expression
AU5486700A (en) Antisense modulation of g-alpha-s1 expression
AU2410600A (en) Antisense modulation of g-alpha-i3 expression
GB9902919D0 (en) Modulator of inflammation
EP1218407A4 (en) Uses of kappa-conotoxin pviia
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
IL130989A0 (en) Variants of alternative splicing
GB9925634D0 (en) Modification of plants
AU5615700A (en) Antisense modulation of g-alpha-i2 expression
AU1489701A (en) Antisense modulation of nck-2 expression
AU5965700A (en) Sigma-delta modulator
PL350963A1 (en) Use of arylalkanoylpyridazines
AU1221101A (en) Antisense modulation of cytohesin-2expression
GB9901444D0 (en) Anti-inflammatory agents
AU5488900A (en) Modulators of fibrosis
GB9928172D0 (en) Modulator

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)